icobrain brain MRI AI platform

Organization
icometrix · Belgium
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

icometrix is a brain imaging AI company founded in 2011 in Leuven, Belgium, as a spin-off from Belgian universities and hospitals, with a US office in Boston. It addresses the need for objective, reproducible measurement of brain MRI in neurological disease.

The icobrain platform extracts quantitative data from brain MRI scans for multiple sclerosis, dementia and Alzheimer's disease, stroke, traumatic brain injury, epilepsy, Parkinson's disease and brain tumors. icobrain aria detects and grades amyloid-related imaging abnormalities (ARIA-E and ARIA-H) in patients on anti-amyloid therapy. Users are hospitals, radiologists, neurologists and pharmaceutical companies running trials.

2. Highlighted features & specifications

  • icobrain: quantitative brain MRI analysis for MS, dementia, stroke, TBI, epilepsy, Parkinson's and brain tumors.
  • icobrain aria: automated detection and quantification of ARIA-E and ARIA-H with a severity score.
  • Longitudinal tracking: follows ARIA and brain changes across successive scans.
  • icolung: AI lung analysis launched in 2020.
  • icompanion: patient care platform for people with multiple sclerosis.
  • Clinical workflow integration: connects to radiology and hospital workflows.

3. Potential application

Memory clinics at Vietnamese tertiary hospitals could use icobrain to quantify brain atrophy on routine MRI. Neurology and MS centers could track lesion and volume change between visits. Hospitals starting anti-amyloid therapy could use icobrain aria for ARIA safety monitoring.

4. Benefits

Gives radiologists and neurologists quantified brain MRI measures instead of purely visual reads.

icobrain aria was validated in a 16-radiologist, 400+ scan study published in JAMA Network Open, with shorter reading time and better inter-reader agreement.

Supports safer prescribing of anti-amyloid treatments through ARIA monitoring.

Serves pharma teams with imaging biomarkers for trials and real-world evidence.

6. Other information

Founded 2011 in Leuven, Belgium, with a US office in Boston. GE HealthCare announced in September 2025 an agreement to acquire icometrix; the site now identifies it as a GE HealthCare company. icobrain aria carries market approval in Europe, Israel, Japan, Switzerland and the UK, and FDA 510(k) clearance.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us